Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00424-023-02903-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Assessment of the clinical effectiveness of a specialized fermented milk product for the dietary correction of carbohydrate and fat metabolism disorders].
Vopr Pitan
January 2025
Limited Liability Company "Pyatigorsk Dairy Plant", 357500, Pyatigorsk, Russian Federation.
To level out the nutrient imbalance in diets, patients with carbohydrate and lipid metabolism disorders are prescribed to include specialized low-fat food with increased protein content. In this regard, the development and evaluation of the effectiveness of such products enriched with micronutrients is relevant. of the research was to evaluate the clinical effectiveness of a specialized fermented milk product for the dietary correction of carbohydrate and fat metabolism disorders.
View Article and Find Full Text PDFImproving the Predictive Strength of Better-Ear Four-Frequency Pure-Tone Average With the Addition of the Tinnitus and Hearing Survey-Hearing Subscale.
Ear Hear
January 2025
Audiology and Speech Pathology Center, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Objectives: The objective of this project was to quantify the relative efficacy of a four-frequency pure-tone average in the better ear (PTA4), the Hearing subscale of the Tinnitus and Hearing Survey (THS-H), and a combination of the two in predicting speech-in-noise performance, hearing aid recommendation, and hearing aid use among United States service members (SMs).
Design: A two-analysis retrospective study was performed. The first analysis examined the degree to which better-ear PTA4 alone, THS-H alone, and better-ear PTA4 in conjunction with THS-H predicted performance on a speech-in-noise test, the modified rhyme test.
Protective factors contributing to the health status of construction industry migrant workers in Chinese mainland.
Sci Rep
January 2025
College of Fine Art and Design, Wenzhou University, Wenzhou, 325035, Zhejiang, China.
Construction industry migrant workers (CIMWs) face high-intensity labor and harsh working environments, experiencing significant health issues. Studying these health issues can help to protect workers' rights, improve labor efficiency, and promote sustainable development in the construction industry. The objective of this study is to analyze the relationships among health status, social support, and marital adjustment in construction migrant workers.
View Article and Find Full Text PDFDesign of an injectable magnetic hydrogel with porous structure and electrocatalytic activity for the sensitive electrochemical detection of nitrite in foods.
Food Chem
January 2025
College of Food Science and Engineering, Shandong Agricultural University, Taian 271018, People's Republic of China. Electronic address:
Herein, we synthesized a novel injectable porous magnetic hydrogel (MHG) at room temperature using carboxymethyl chitosan (CMCS), polydopamine (PDA), sodium alginate (SA), polyethyleneimine (PEI) and copper ferrite (CuFeO) as building blocks. The CMCS and SA as monomers provided good film-forming and anti-fouling properties for MHG. The PDA-coated CuFeO as a cross-linking agent improved the homogeneity, adsorption and electrocatalytic performance of MHG, but also generated a macroporous hydrogel structure which was beneficial for sensing applications.
View Article and Find Full Text PDFA Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix Vaccine When Given to Healthy Infants at 3 and 12 Months of Age.
Infect Dis Ther
January 2025
Vaccine Research and Development, Pfizer R&D UK Ltd, Marlow, UK.
Introduction: Infants and young children typically have the highest age-related risk of invasive meningococcal disease. The immunogenicity and safety of a single primary dose and a booster of a meningococcal A/C/W/Y tetanus toxoid conjugate vaccine (MenACWY-TT; Nimenrix) in infants were evaluated.
Methods: In this phase 3b, open-label, single-arm study, healthy 3-month-old infants received a single Nimenrix dose followed by a booster at age 12 months (1 + 1 series).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!